Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say

Trump's FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink approved for new studies, company says.

Business - CNBC - 19 hours ago

Trump picks Dr. Marty Makary, a Johns Hopkins surgeon, for FDA chief

President-elect Donald Trump on Friday nominated Dr. Marty Makary, a pancreatic surgeon at Johns Hopkins University, as commissioner of the FDA.

Trump likely to choose surgeon and writer Marty Makary as FDA chief

Johns Hopkins doctor touted protection from natural immunity and opposed Covid vaccine mandates. Donald Trump is likely to choose the Johns Hopkins surgeon and writer Martin Makary to lead the Food ...

World - The Guardian - 6 days ago

Meet Trump's picks for CDC, FDA

Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Trump picks heads of CDC, FDA and surgeon general President-elect Trump has announced his choices for the ...

Politics - The Hill - Yesterday

Outcry over stalemate on Gaetz report; Bernie Sanders’ Senate vote on blocking some arms to Israel fails – US politics live

Democrat Susan Wild says committee chair Michael Guest mischaracterized meeting and committee will reconvene in December; US Senate to also vote on two resolutions on mortar rounds and a GPS ...

World - The Guardian - 6 days ago

Johns Hopkins surgeon and COVID contrarian Marty Makary selected to lead Trump’s FDA

President-elect Trump has picked Marty Makary, a Johns Hopkins's surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a ...

Politics - The Hill - 4 days ago

Trump taps a Fox News personality, a surgeon and a former Congressman to lead public health agencies

President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration

Health - ABC News - 4 days ago

Trump nominates Marty Makary, who opposed COVID vaccine mandates, to head FDA

President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.

Dr Martin Makary Chosen to Head the FDA

A frequent Fox News commentator, Dr. Makary has a penchant for challenging the medical establishment, and stirred pandemic concerns with his views on Covid immunity and vaccine mandates.

Business - The New York Times - 4 days ago

Pharma shares hit as Trump picks RFK Jr to lead health department

Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK. Who is RFK Jr and what are his likely top priorities? Business live – latest ...

World - The Guardian - November 15

JPMorgan may be ‘best in class’ but it’s time to take profits, analyst says

Baird’s David A. George downgrades megabank to underperform because it’s “more than fully priced” at recent levels.

Business - MarketWatch - November 7

Trump announces labor secretary, FDA chief, and several other cabinet picks

President-elect Donald Trump has announced several selections to his cabinet including Scott Bessent as treasury secretary and Lori Chavez-Deremer as labor secretary. NBC News' Aaron Gilchrist has ...

Politics - NBC News - 4 days ago

Trump rounds out health team with CDC, FDA picks

President-elect Trump rounded out his health team for his upcoming White House term by announcing his Centers for Disease Control and Prevention (CDC), Federal Drug Administration (FDA) and surgeon ...

Politics - The Hill - 3 days ago

Trump rounds out final cabinet picks with labor secretary, FDA chief

President-elect Trump has now named all 15 of his cabinet picks after a flurry of announcements. Trump picked a team of doctors to work with his choice for health secretary, Robert F. Kennedy Jr., ...

Politics - NBC News - 3 days ago

Biden COVID response coordinator: Trump picks for FDA, NIH 'pretty reasonable'

Ashish Jha, the dean of the Brown University School of Public Health and former White House coronavirus coordinator under President Biden, said President-elect Trump’s picks to lead the Food and ...

Politics - The Hill - Yesterday

‘Sigh of relief’: Wall Street welcomes Trump’s pick of Bessent for Treasury

Nomination of hedge fund investor follows tumultuous fight for the top US economic post

Business - Financial Times - 4 days ago

Pharma stocks sink on RFK Jr. pick

Welcome to The Hill's Business & Economy newsletter {beacon} Business & Economy Business & Economy The Big Story Pharma stocks sink after RFK Jr. tapped to lead HHS Several pharmaceutical and ...

Politics - The Hill - November 15

Biden needs to push through promised student-loan relief before Trump returns to White House, powerful Democrat warns

The Biden administration needs to move quickly to cancel the student loans of borrowers who were already promised relief before President-elect Donald Trump takes office or risk having this White ...

Business - MarketWatch - 4 days ago

The Trump effect is 30% priced in, says Deutsche Bank analyst — here’s why

One of the big questions confronting markets is just how much of the impact of a Donald Trump presidency has been priced even before it starts.

Business - MarketWatch - 5 days ago

Trump picks Johns Hopkins surgeon who argued against COVID lockdowns to lead FDA

President-elect Donald Trump picks Johns Hopkins surgeon Marty Makary, who argued against pandemic lockdowns, to lead the U.S. Food and Drug Administration.

What Trump's strategy may be with controversial Cabinet picks

Some of President-elect Donald Trump's early Cabinet picks, particularly Robert F. Kennedy Jr. for HHS secretary and Matt Gaetz for attorney general, have come with controversy and criticism. CBS ...

Trump's return may force Europe's hand on China and Ukraine

Europe is home to some of the U.S.' closest and allies. But as President-elect Donald Trump prepares to take office, their priorities may be diverging.

Politics - NBC News - 5 days ago

AstraZeneca embarks on major US expansion

UK’s largest drugmaker to invest $3.5bn by end of 2026 as it targets doubling of revenues

Business - Financial Times - November 12

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.

Business - CNBC - November 13

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

Business - CNBC - November 19

Trump 2.0 would need 53 GOP senators for a ‘truly reliable’ majority, analyst says

If Republican nominee Donald Trump is elected president, he would need 53 GOP senators to have a “truly reliable” Senate majority, reckons one analyst. With a Kamala Harris presidency, certain GOP ...

Business - MarketWatch - October 31

Space stocks saw big gains this week in part due to 'Trump-Elon trade' rally, analysts say

Several pure-play space stocks rallied 20% or more this week, in part driven by what sector analysts say is a "Trump-Elon trade."

Business - CNBC - November 15

Robert Kennedy Jr’s influence over Trump sparks Big Pharma alarm

Vaccine sceptic expected to hold sway over health policy and top appointments

World - Financial Times - November 8

FirstFT: Trump’s first appointment

Also in today’s newsletter, Fed cuts rates and Citi revamps wealth banker pay

World - Financial Times - November 8

Trump picking Gaetz for AG may be loyalty test for senators

President-elect Donald Trump's choice for attorney general, Matt Gaetz, is facing a tough Senate confirmation process for the job. CBS News political director Fin Gómez reports on some of the ...

McConnell may play key role on Trump’s controversial Cabinet picks

Senate Minority Leader Mitch McConnell (R-Ky.) will be under the microscope when it comes to President-elect Trump’s most contentious Cabinet nominees, with senators watching closely to see if he ...

Politics - The Hill - November 17

Stephen A. Smith: Trump may have ulterior motive for Gaetz pick

Stephen A. Smith says that “under normal circumstances” Matt Gaetz would never be confirmed as the nation's new attorney general.

Politics - The Hill - 6 days ago

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Business - MarketWatch - November 14

Why Microsoft’s stock selloff may be a buying opportunity, according to analysts

Microsoft’s guidance disappointed, but analysts see the stock as less crowded nowadays — with ample AI opportunity ahead.

Business - MarketWatch - October 31

Banks may face uncertainties after election euphoria fades: analyst

Moody’s banking strategist Chris Stanley sees potential headwinds along with positive trends for banks in a new Trump administration.

Business - MarketWatch - November 11

Biden's final months may offer conflict opportunities, even as Trump's return looms

President Joe Biden will see out his term knowing that President-elect Donald Trump -- a man he called a "genuine danger to American security" -- will succeed him.

Latest in Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say